Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 47 Records) |
Query Trace: Breast Neoplasms and ERCC1[original query] |
---|
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy. Journal of translational medicine 2014 12 (1): 272. Palomba Grazia, Atzori Francesco, Budroni Mario, Ombra MariaNeve, Cossu Antonio, Sini MariaCristina, Pusceddu Valeria, Massidda Bruno, Frau Barbara, Notari Francesca, Ionta MariaTeresa, Palmieri Giusep |
Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer. PloS one 2014 9 (6): e99843. Du Yan, Su Tong, Zhao Lijun, Tan Xiaojie, Chang Wenjun, Zhang Hongwei, Cao Guangw |
SNPs and taxane toxicity in breast cancer patients. Pharmacogenomics 2014 15 (15): 1845-58. Bosó Virginia, Herrero María José, Santaballa Ana, Palomar Laura, Megias Juan E, de la Cueva Helena, Rojas Luis, Marqués María Remedios, Poveda José Luis, Montalar Joaquin, Aliño Salvador |
ERCC1 and CYP1B1 polymorphisms as predictors of response to neoadjuvant chemotherapy in estrogen positive breast tumors. SpringerPlus 2015 4 327. Dumont Aurélie, Pannier Diane, Ducoulombier Agnès, Tresch Emmanuelle, Chen Jinying, Kramar Andrew, Révillion Françoise, Peyrat Jean-Philippe, Bonneterre Jacqu |
The C8092A polymorphism in the ERCC1 gene and breast carcinoma risk: a meta-analysis of case-control studies. International journal of clinical and experimental medicine 2015 8 (3): 3691-9. Guo Xu-Guang, Wang Qian, Xia Yong, Zheng L |
DNA repair genes XRCC1 and ERCC1 polymorphisms and the risk of sporadic breast cancer in Han women in the Gansu Province of China. Genetic testing and molecular biomarkers 2015 Jul 19 (7): 387-93. Zhu Gongjian, Wang Lan, Guo Hongyun, Lu Lingeng, Yang Suisheng, Wang Tao, Guo Huan, Wang Haitao, Min Jianping, Yang Kai, Chen Xuezhong, Liu Yuanqiang, Wang Zhiping, Su Haixia |
Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer. Oncology letters 2015 Apr 9 (4): 1657-1661. Gómez-Díaz Benjamín, DE LA Luz Ayala-Madrigal María, Gutiérrez-Angulo Melva, Valle-Solis Aura Erazo, Linares-González Luis Miguel, González-Guzmán Roberto, Cruz-Guillén David, Cedeño-Garcidueñas Ana Lilia, Canto Patricia, López-Hernández Luz Bereni |
Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel. OncoTargets and therapy 2016 9 5073-80. Kus Tulay, Aktas Gokmen, Kalender Mehmet Emin, Demiryurek Abdullah Tuncay, Ulasli Mustafa, Oztuzcu Serdar, Sevinc Alper, Kul Seval, Camci Celaletd |
Analysis of DNA Repair Genes Polymorphisms in Breast Cancer. Pathology oncology research : POR 2016 Aug . Romanowicz Hanna, Pyziak ?ukasz, Jab?o?ski Filip, Bry? Magdalena, Forma Ewa, Smolarz Bea |
Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2016 Oct 7 (41): 66790-66808. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Grzybowska E |
Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population. Genetics and molecular research : GMR 2016 15 (1): . Zhao R, Ying M |
Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: A hospital-based observational study. Medicine 2016 Nov 95 (44): e5151. Tsuji Daiki, Ikeda Midori, Yamamoto Keisuke, Nakamori Harumi, Kim Yong-Il, Kawasaki Yohei, Otake Aki, Yokoi Mari, Inoue Kazuyuki, Hirai Keita, Nakamichi Hidenori, Tokou Umi, Shiokawa Mitsuru, Itoh Kunihi |
Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population. Oncotarget 2016 Oct . He Bang-Shun, Xu Tao, Pan Yu-Qin, Wang Han-Jin, Cho William C, Lin Kang, Sun Hui-Ling, Gao Tian-Yi, Wang Shu-K |
Association between ERCC1 Polymorphism and the Risk and Clinicopathological Features of Breast Cancer in Thai Women in the Lower Northeastern Region. Asian Pacific journal of cancer prevention : APJCP 2017 11 18 (11): 2999-3002. Pongsavee Malinee, Wisuwan Kamol, Tiwawech Dan |
Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk. PloS one 2018 13 (8): e0202112. Tsai Chia-Wen, Chang Wen-Shin, Shen Te-Chun, Su Chen-Hsien, Wang Hwei-Chung, Liu Liang-Chih, Bau Da-Ti |
Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer. Frontiers in genetics 2018 9 161. Torrezan Giovana T, de Almeida Fernanda G Dos Santos R, Figueiredo Márcia C P, Barros Bruna D de Figueiredo, de Paula Cláudia A A, Valieris Renan, de Souza Jorge E S, Ramalho Rodrigo F, da Silva Felipe C C, Ferreira Elisa N, de Nóbrega Amanda F, Felicio Paula S, Achatz Maria I, de Souza Sandro J, Palmero Edenir I, Carraro Dirce |
Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 May . Anurag Meenakshi, Punturi Nindo, Hoog Jeremy, Bainbridge Matthew N, Ellis Matthew J, Haricharan Svas |
ERCC1 rs11615 polymorphism increases susceptibility to breast cancer: a meta-analysis of 4547 individuals. Bioscience reports 2018 May . Li Bingjie, Shi Xiaoqing, Yuan Yingying, Peng Mengle, Jin Huifang, Qin Dongch |
DNA repair and apoptosis: Roles in radiotherapy-related acute reactions in breast cancer patients. Cellular and molecular biology (Noisy-le-Grand, France) 2018 Mar 64 (4): 64-70. Batar Bahadir, Mutlu Tuba, Bostanci Merve, Akin Mustafa, Tuncdemir Matem, Bese Nuran, Guven Mehm |
Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018 Feb 9 (10): 9114-9136. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E |
Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing. Breast cancer research and treatment 2019 Sep . Scarpitta R, Zanna I, Aretini P, Gambino G, Scatena C, Mei B, Ghilli M, Rossetti E, Roncella M, Congregati C, Bonci F, Naccarato A G, Palli D, Caligo M |
Beyond DNA repair: the novel immunological potential of PARP inhibitors. Molecular & cellular oncology 2019 5 6 (2): 1585170. Chabanon Roman M, Soria Jean-Charles, Lord Christopher J, Postel-Vinay Soph |
Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility. Journal of cellular biochemistry 2019 May . Yang Fan, Mu Xiyan, Bian Ce, Zhang Huan, Yi Tao, Zhao Xia, Lin Xiaoju |
MassARRAY-based single nucleotide polymorphism analysis in breast cancer of north Indian population. BMC cancer 2020 9 20 (1): 861. Bakshi Divya, Nagpal Ashna, Sharma Varun, Sharma Indu, Shah Ruchi, Sharma Bhanu, Bhat Amrita, Verma Sonali, Bhat Gh Rasool, Abrol Deepak, Sharma Rahul, Vaishnavi Samantha, Kumar Rake |
Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China. Cancer medicine 2020 Oct . Li Hongtao, Zhou Linghui, Ma Jing, Zhu Yuyao, Fan Jingjing, Li Na, Zheng Yi, Sha Tong, Zhai Zhen, Ma Binlin, Dai Zhij |
Impact of Neoantigen Expression and T-Cell Activation on Breast Cancer Survival. Cancers 2021 Jun 13 (12): . Li Wenjing, Amei Amei, Bui Francis, Norouzifar Saba, Lu Lingeng, Wang Zuohe |
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3. The oncologist 2021 5 26 (7): e1143-e1155. Iwata Hiroji, Umeyama Yoshiko, Liu Yuan, Zhang Zhe, Schnell Patrick, Mori Yuko, Fletcher Olivia, Marshall Jean-Claude, Johnson Jillian G, Wood Linda S, Toi Masakazu, Finn Richard S, Turner Nicholas C, Bartlett Cynthia Huang, Cristofanilli Massi |
Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers. NPJ breast cancer 2021 Nov 7 (1): 143. Alblihy Adel, Shoqafi Ahmed, Toss Michael S, Algethami Mashael, Harris Anna E, Jeyapalan Jennie N, Abdel-Fatah Tarek, Servante Juliette, Chan Stephen Y T, Green Andrew, Mongan Nigel P, Rakha Emad A, Madhusudan Srinivas |
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients. Frontiers in immunology 2023 6 14 1188030. Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, Julian Hölzenbein, Esther Schwich, Sabine Schramm, Hana Rohn, Peter A Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebma |
Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso. Molecular genetics & genomic medicine 2023 1 e2134. Adico Marc Donald Wilfried, Zouré Abdou Azaque, Sombié Herman Karim, Kiendrebeogo Touwendpoulimdé Isabelle, Dabré Soayebo, Amegnona Lanyo Jospin, Bakyono Bélélé Siméon, Traoré Lassina, Ouedraogo Teega-Wendé Clarisse, Ouedraogo Rogomenoma Alice, Zohoncon Théodora M, Yonli Albert Théophane, Bayala Bagora, Bambara Hierrhum Aboubacar, Djigma Florencia W, Simpore Jacqu |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: